Printer Friendly

Carotid Artery Endarterectomy Effect on Choroidal Thickness: One-Year Follow-Up.

1. Introduction

Atherosclerotic carotid disease is an important cause of cerebrovascular accidents (CVAs) and transient ischemic attack (TIA). Furthermore, it may lead to ischemia in areas downstream to the stenotic lesion. Previous studies showed that a 90% carotid stenosis can reduce the ipsilateral central retinal artery perfusion pressure by approximately 50% [1-4] and as the degree of internal carotid artery (ICA) stenosis increases, the flow in ophthalmic artery decreases. In severe stenosis, the flow is not detectable or a reversed flow may be present [5-7]. Amaurosis fugax (AF), central retinal artery occlusion, and ocular ischemic syndrome (OIS) are among the problems of carotid disease and may eventually lead to permanent blindness [1, 8, 9]. Doppler ultrasonography is used for the measurement of blood flow in the carotid arteries; many techniques have been developed for the measurement of ocular blood flow and velocity. Though perfusion of both the ophthalmic artery and central retinal artery can be measured in experienced hands [10], this may be less feasible in standard clinical settings [9].

In the case of moderate to severe stenosis of carotid arteries and ischemic diseases of the brain such as CVA or TIA, carotid artery surgery is the most effective method of treatment [11, 12]. Disappearance of AF, decreased neovascularization of the optic nerve head and the iris, disappearance of paresis of the pupil muscle, and improvement of blood flow in orbital vessels have all been reported following carotid artery endarterectomy (CEA) [13-16]. In OIS, CEA has been reported to lead to subjective improvement in visual acuity and periorbital pain and improvement or complete resolutions of signs of ischemia in funduscopic examination [17].

Ultrasonic studies have revealed a significant decrease of choroidal thickness in patients with hemodynamically significant stenosis of the carotid arteries [18]. Other studies, using optical coherence tomography (OCT) images, have shown that affected eyes with OIS showed thinner subfoveal choroidal thickness than unaffected contralateral eyes [18-23], meaning that subfoveal choroid thinning represents impaired choroidal circulation in patients with OIS.

The purpose of this study was to assess choroidal and central macular thickness before and after CEA surgery.

2. Materials and Methods

This is a prospective case series of patients who underwent CEA between 4/2015 and 12/2015 in the Tel Aviv Medical Center. According to conventional guidelines, CEA was performed in the presence of ICA stenosis of 50% to 99% [12, 24].

The study adhered to the tenets of the Declaration of Helsinki and was approved by the Institutional Review Board (IRB) of the Tel Aviv Medical Center, Tel Aviv, Israel. Approval and informed consent was obtained from all patients.

2.1. Retinal and Choroidal Measurements. Spectral domain optical coherence tomography (SD-OCT) (Spectralis OCT; Heidelberg Engineering, Heidelberg, Germany) was performed one day before the CEA and at least 6 months after the procedure. Measurements included central macular thicknesses (CMTs) and choroidal thickness. Choroidal thickness measurement was made with the use of enhanced-depth imaging (EDI) SD-OCT. All measurements were performed between 9 and 11:30 AM in order to deal with the potential effect of diurnal variation.

Choroidal thickness was measured as the perpendicular distance between the hyperreflective outer border of the retinal pigment epithelial layer and the sclerochoroidal interface (Figure 1). We measured subfoveal and 500 [micro]m, 1000 [micro]m, and 1500 [micro]m nasal and temporal to the subfoveal measurement.

2.2. Data Collection. All patients underwent a complete ophthalmic examination, and the data collected included patients' demographics, medical history, smoking history (evaluated in pack-years, i.e., one pack-year = 20 cigarettes/ day for one year), percentage of carotid stenosis before and after CEA, best-corrected visual acuity (BCVA), slit-lamp examination and fundoscopy findings, CMT, and choroidal thickness. Patients under the age of 18, with insufficient or poor-quality images, other retinal or choroidal disease (such as retinal artery occlusion, retinal vein occlusion, uveitis, age-related macular degeneration (AMD), central serous chorioretinopathy (CSR), and polypoidal choroidal vasculopathy (PCV)), macular pathologies (including epiretinal membrane, cystoid macular edema, subretinal fluid, macular hole, or atrophy), or high myopia, were excluded. The main outcome was change in choroidal thickness before and after CEA.

2.3. Data Analysis. BCVA was recorded using a Snellen chart and was converted to the logarithm of minimal angle of resolution (logMAR) value for statistical purposes. When dealing with variables that were not normally distributed, the Mann-Whitney test was used. Student's t-test was used to compare parameters between groups. Data were recorded in Microsoft Excel (2010)[TM] and analyzed using SPSS version 23 (SPSS Inc., Chicago, IL, USA). All tests were 2-tailed, and the threshold for statistical significance was defined as a p value < 0.05. Continuous variables are described as mean [+ or -] standard deviation.

3. Results

A total of 12 patients were recruited, two passed away and two were lost during the follow-up period. A total of eight patients (seven male and one female) completed the follow-up and were included in this study.

3.1. Patient Characteristics. The mean age of the patients was 70.5 [+ or -] 6.1 (range 61-77) years. All the patients suffered from hypertension (HTN) and had a medical history of CVA or TIA. Most of the patients were smokers and had a history of hypercholesterolemia. Five patients had right-side and three left-side significant ICA (p = 0.35). Mean ICA stenosis was 89.8% [+ or -] 5.1 in the operated side, compared to 33.7% [+ or -] 10.9 in the nonoperated side (p < 0.0001) and to 0% after CEA (p < 0.0001). Operated side BCVA was 0.35 [+ or -] 0.66 compared to 0.61 [+ or -] 0.83 in the nonoperated side (p = 0.51). The lower vision in the nonoperated side was attributed to hand motion and 6/30 and 6/60 vision in three patients due to cataract and absent posterior segment morbidities. The characteristics and demographic features of the patients are demonstrated in Tables 1 and 2.

3.2. Choroidal and Retinal Measurements. The mean subfoveal choroidal thickness (SFChT) of the operated side was 277 [+ or -] 67 [micro]m compared to 268 [+ or -] 71 [micro]m in the nonoperated side (p = 0.81). When comparing the choroidal thickness measurements of the operated side to the nonoperated side in six other locations such as 500 [micro]m, 1000 [micro]m, 1500 [micro]m nasal and 500 [micro]m, 1000 [micro]m, and 1500 [micro]m temporal relative to the SFChT measurement, we did not find any statistically significant difference (p = 0.80, 0.92, 0.52, 0.63, 0.89, 0.75, respectively). CMT of the operated side was 267 [+ or -] 31 [micro]m compared to 271 [+ or -] 19 [micro]m in the nonoperated side (p = 0.76) (Table 3).

The second measurements of the SFChT were performed at 14.3 [+ or -] 4 (range 6-19) months after the first one. At the time of the second measurements, average ICA stenosis was 0% in the operated side (p < 0.0001). SFChT after CEA was 275 [+ or -] 64 [micro]m (p = 0.96). When comparing the choroidal thickness measurements, before and after CEA, in the other six locations as previously described, no statistically significant difference was found (p = 0.85, 0.97, 0.74, 0.95, 0.91, 0.78, respectively). CMT after CEA was 268 [+ or -] 29 [micro]m (p = 0.98) (Table 4).

Figures 2 and 3 show the follow-up SD-OCT images of 2 patients.

3.3. Post Hoc Power Analysis. Assuming that the difference in SFChT before and after surgery would be real, we calculated at a power of 0.8 that 8,421 subjects would be required for this difference to reach the 0.05 significance level.

4. Discussion

ICA stenosis can cause a decrease in ophthalmic artery flow and as a result can cause ocular complications, including AF, central retinal artery occlusion, and OIS [3, 4, 25]. There is sufficient evidence to suggest that CEA has a positive effect for patients with OIS and that the earlier treatment is instituted the better the clinical outcome [3]. However, when to intervene and whether or not it is of benefit for patients without ocular pathology is still unclear [26]. In our study, we examined patients with significant ICA stenosis but without any ocular pathology, besides cataract. All the patients in our study had severe ICA stenosis, suffered from HTN, and had a medical history of CVA or TIA. These findings correlate with previous studies which demonstrated patients with ICA stenosis suffer from other arteriovascular disease such as coronary artery disease, TIA, CVA and have a higher rate of HTN, hypercholesterolemia, and diabetes mellitus [27-31].

Previous studies show that SFChT in the normal population varies between 260 and 300 [micro]m [32-36]. There are several conditions and diseases that can cause a change in choroidal thickness such as AMD and myopia that result in thinner choroid or PCV and CSR that result in thicker choroid [37-45]. In our study, at presentation, we found SFChT of 277 [+ or -] 67 [micro]min the operated side compared to 268 [+ or -] 71 [micro]m in the nonoperated side (within the range of normal SFChT). This finding was surprising, as not only did we not find a thinner SFChT on the operated side but it was slightly thicker. Only few studies examined SFChT in the presence of ICA stenosis, and they showed contradicting findings. Akcay et al. showed similar findings to ours. They examined 21 patients with more than 70% ICA stenosis on one side and less than 70% stenosis in the fellow ICA. They found SFChT of 231 [micro]m on the stenotic side, compared to 216 [micro]m on the other side. Their theory is that the increased SFChT that was observed at the stenotic side might be a result of choriocapillaris vasculature dilatation, aimed to prevent retinal and choroidal ischemia due to the diminished blood flow caused by the ICA stenosis [21]. Contrarily, other studies found different results. Sayin et al. compared 25 patients with ICA stenosis and 25 age- and gender-matched healthy individuals and found a significantly thinner SFChT in the study group. Nevertheless, no significant correlation between the degree of ICA stenosis and the SFChT was found [22]. Wang et al. retrospectively examined 219 patients and found that mean SFChT of the ICA stenosis group was significantly lower than that of normal eyes. They concluded that ICA stenosis can influence the blood flow of the posterior ciliary arteries, which results in an insufficient blood perfusion of choriocapillaris [46]. Ivashina et al. found mixed results when examining 12 patients with significant ICA stenosis and found the choroid thickness was reduced only in 3 patients [18]. In cases of ICA and OIS, previous studies found choroidal thickness and volume of OIS eyes were smaller than those of unaffected fellow eyes [19, 23]. OIS results from chronic ocular hypoperfusion due to stenosis [3]; thus, the results of thinner SFChT are expected.

During our follow-up, after a median period of 14 months, we did not find any change in choroidal thickness and CMT of the operated side. In this study, we focused on change in choroidal thickness and CMT after CEA for patients with normal fundoscopy findings. These findings stand in somewhat contrast to previous studies who examined the effects of carotid artery surgery on ocular blood flow. Riihelainen et al. examined 17 patients and concluded that CEA resulted in significantly increased flow in the central retinal artery and ophthalmic artery [47]. Kobayashi et al. examined 45 patients and demonstrated an increase in retinal artery pressure [2]. Costa et al. reported 17 patients with severe ICA stenosis and found that hemodynamic changes in patients undergoing CEA suggest improvement in the ipsilateral retrobulbar blood flow [25]. Other studies found an improvement in ophthalmic artery blood flow and improvement in visual acuity for patients with OIS after CEA [17, 48-50].

A potential theory is that, in patients with ICA stenosis but without OIS or other ocular ischemic findings, the ocular blood flow can be reduced or normal, depending on the ophthalmic artery blood flow. The ophthalmic artery blood flow (and not the upstream carotid artery blood flow) before CEA will determine the improvement in ocular perfusion after CEA. If there is a decrease in ophthalmic artery blood flow due to ICA stenosis, it will improve after CEA [5-7] and will result in an increase in choroidal thickness. If there is no decrease in ophthalmic artery blood flow, there will be no change in choroidal thickness after CEA. We speculate that, in our patients who had normal choroidal thickness and did not demonstrate any pathological fundoscopy findings, despite significant ICA stenosis, the ophthalmic artery blood flow was sufficiently preserved. Thus, there was no change in choroidal thickness during the follow-up despite improvement in carotid artery flow. Unfortunately, this remains a theory as we did not measure the ophthalmic artery blood flow in our patients before and after CEA.

Recently, Lareyre et al. recently reported that, in patients with severe ICA without ocular symptoms or findings, choroidal thickness increased bilaterally after CEA in patients, more so on the ipsilateral side [51]. These findings contradict those of the current study where in a similar cohort of patients, no such improvement in choroidal thickness was detected. A potential explanation is that though CEA improves ocular blood flow and pressure, it does not necessarily change morphology of the blood vessels, particularly when there is atherosclerosis. Indeed Akcay et al. previously demonstrated that there may even be a compensatory choroidal thickness increase in ipsilateral internal carotid artery stenosis greater than 70% [21]. As such, further larger prospective studies combining multiple imaging modalities may shed light on this controversial matter.

The main limitations of our study are small sample size and lack of ultrasonography of the ophthalmic artery and other ocular blood vessels. The small sample size could lead to type II error; however, assuming that the clinically insignificant difference in SFChT before and after CEA surgery (2 [micro]m) would be real, 8,421 subjects would be required for this difference to reach statistical significant, a feat that would be nearly impossible to carry out. With that being said, a larger scale cohort is needed in order to further strengthen our preliminary findings. An additional limitation of this study is that fluorescein angiography was not routinely performed before and after CEA. Similarly, axial length was not routinely measured in these patients, and as such, we cannot comment on any correlation between flow and axial length. Further studies may consider incorporating these modalities as well. Last, it may be that an increase in choroidal thickness would be easier to identify in patients with thinner preoperative choroidal thickness, and future studies may consider studying the effect of CEA on these patients.

In summary, this study reports that SFChT and CMT in patients with normal fundoscopy exam and significant ICA stenosis can be normal and may not change after ipsilateral CEA.

https://doi.org/10.1155/2018/8324093

Data Availability

The data used to support the findings of this study are available from the corresponding author upon request.

Conflicts of Interest

The authors declare that they have no conflicts of interest.

References

[1] R. Cohen, J. Padilla, D. Light, and R. Diller, "Carotid artery occlusive disease and ocular manifestations: importance of identifying patients at risk," Optometry: Journal of American Optometric Association, vol. 81, no. 7, pp. 359-363, 2010.

[2] S. Kobayashi, R. W. Hollenhorst, and T. M. Sundt, "Retinal arterial pressure before and after surgery for carotid artery stenosis," Stroke, vol. 2, no. 6, pp. 569-575, 1971.

[3] E. Mendrinos, T. G. Machinis, and C. J. Pournaras, "Ocular ischemic syndrome," Survey of Ophthalmology, vol. 55, no. 1, pp. 2-34, 2010.

[4] T. P. Kearns, R. G. Siekert, and T. M. Sundt, "The ocular aspects of bypass surgery of the carotid artery," Mayo Clinic Proceedings, vol. 54, pp. 3-11, 1979.

[5] N. K. Altinbas, E. Ustuner, H. Ozcan, S. Bilgic, T. Sancak, and E. Dusunceli, "Effect of carotid artery stenting on ophthalmic artery flow patterns," Journal of Ultrasound in Medicine, vol. 33, no. 4, pp. 629-638, 2014.

[6] C.-H. Liu, C.-H. Chang, T.-Y. Chang et al., "Carotid artery stenting improves cerebral hemodynamics regardless of the flow direction of ophthalmic artery," Angiology, vol. 66, no. 2, pp. 180-186, 2014.

[7] A. A. Drakou, A. G. Koutsiaris, S. V. Tachmitzi, N. Roussas, E. Tsironi, and A. D. Giannoukas, "The importance of ophthalmic artery hemodynamics in patients with atheromatous carotid artery disease," International Angiology: A Journal of International Union of Angiology, vol. 30, no. 6, pp. 547-554, 2011.

[8] L. Quaranta and O. Braga, "The effect of endarterectomy on ocular blood velocity," Ophthalmology, vol. 105, no. 3, pp. 389-390, 1998.

[9] T. H. Williamson and A. Harris, "Ocular blood flow measurement," British Journal of Ophthalmology, vol. 78, no. 12, pp. 939-945, 1994.

[10] J. Wang, W. Wang, B. Jin et al., "Improvement in cerebral and ocular hemodynamics early after carotid endarterectomy in patients of severe carotid artery stenosis with or without contralateral carotid occlusion," BioMed Research International, vol. 2016, Article ID 2901028, 9 pages, 2016.

[11] G. J. Hankey, "The effect of treating people with reversible ischaemic attacks of the brain and eye on the incidence of stroke in Australia," Australian and New Zealand Journal of Medicine, vol. 27, no. 4, pp. 420-430, 2008.

[12] A. L. Abbott, K. I. Paraskevas, S. K. Kakkos et al., "Systematic review of guidelines for the management of asymptomatic and symptomatic carotid stenosis," Stroke, vol. 46, no. 11, pp. 3288-3301, 2015.

[13] North American Symptomatic Carotid Endarterectomy Trial Collaborators, H. J. M. Barnett, D. W. Taylor et al., "Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis," New England Journal of Medicine, vol. 325, no. 7, pp. 445-453, 1991.

[14] G. Geroulakos, "Carotid surgery and ocular ischaemia," European Journal of Vascular and Endovascular Surgery, vol. 14, no. 5, p. 417, 1997.

[15] D. Hejcmanova, R. Jebava, P. Kunc, Z. Belobradek, A. Krajina, and H. Langrova, "[Treatment of internal carotid artery occlusion and the ocular ischemic syndrome]," Ceskaa Slovenska Oftalmologie, vol. 54, no. 6, pp. 362-367, 1998.

[16] L. J. Balcer, S. L. Galetta, D. M. Yousem, M. A. Golden, and A. K. Asbury, "Pupil-involving third-nerve palsy and carotid stenosis: rapid recovery following endarterectomy," Annals of Neurology, vol. 41, no. 2, pp. 273-276, 1997.

[17] J. R. Rubin, K. M. McIntyre, M. C. Lukens, E. J. Plecha, and V. M. Bernhard, "Carotid endarterectomy for chronic retinal ischemia," Surgery, Gynecology and Obstetrics, vol. 171, no. 6, pp. 497-501, 1990.

[18] A. I. Ivashina, D. I. Ioffe, A. V. Zolotarevskii, G. D. Mikhailova, and G. I. Kuntsevich, "[Dynamics of changes in the thickness of the choroid in patients with stenosis of the internal carotid artery]," Vestnik Oftalmologii, vol. 105, no. 4, pp. 65-67, 1989.

[19] D. Y. Kim, S. G. Joe, J. Y. Lee, J.-G. Kim, and S. J. Yang, "Choroidal thickness in eyes with unilateral ocular ischemic syndrome," Journal of Ophthalmology, vol. 2015, Article ID 620372, 5 pages, 2015.

[20] H. Enaida, S. Nagata, A. Takeda, S. Nakao, Y. Ikeda, and T. Ishibashi, "Changes in chorioretinal blood flow velocity and cerebral blood flow after carotid endarterectomy," Japanese Journal of Ophthalmology, vol. 60, no. 6, pp. 459-465, 2016.

[21] B. I. S. Akcay, E. Kardes Kardes, S. Macin et al., "Evaluation of subfoveal choroidal thickness in internal carotid artery stenosis," Journal of Ophthalmology, vol. 2016, Article ID 5296048, 6 pages, 2016.

[22] N. Sayin, N. Kara, F. Uzun, and I. F. Akturk, "A quantitative evaluation of the posterior segment of the eye using spectral-domain optical coherence tomography in carotid artery stenosis: a pilot study," Ophthalmic Surgery, Lasers and Imaging Retina, vol. 46, no. 2, pp. 180-185, 2015.

[23] H. M. Kang, C. S. Lee, and S. C. Lee, "Thinner subfoveal choroidal thickness in eyes with ocular ischemic syndrome than in unaffected contralateral eyes," Graefe's Archive for Clinical and Experimental Ophthalmology, vol. 252, no. 5, pp. 851-852, 2014.

[24] M. D. Walker, J. R. Marler, M. Goldstein et al., "Endarterectomy for asymptomatic carotid artery stenosis. Executive committee for the asymptomatic carotid atherosclerosis study," JAMA, vol. 273, no. 18, pp. 1421-1428, 1995.

[25] V. P. Costa, S. Kuzniec, L. J. Molnar, G. G. Cerri, P. Puech-Leao, and C. A. Carvalho, "The effects of carotid endarterectomy on the retrobulbar circulation of patients with severe occlusive carotid artery disease," Ophthalmology, vol. 106, no. 2, pp. 306-310, 1999.

[26] F. Bandello and M. B. Parodi, inOcular Ischemic Syndrome Medical Retina, vol. 1, 2012.

[27] D. Mazzaccaro, S. Stegher, M. T. Occhiuto et al., "Treatment of significant carotid artery stenosis in 1824 patients," Journal of Cardiovascular Surgery, vol. 56, no. 1, pp. 107-118, 2015.

[28] S. Chaturvedi and P. Bhattacharya, "Large artery atherosclerosis," CONTINUUM: Lifelong Learning in Neurology, vol. 20, pp. 323-334, 2014.

[29] K. Yoshida and S. Miyamoto, "Evidence for management of carotid artery stenosis," Neurologia Medico-Chirurgica, vol. 55, no. 3, pp. 230-240, 2015.

[30] J. Constantinou, P. Jayia, and G. Hamilton, "Best evidence for medical therapy for carotid artery stenosis," Journal of Vascular Surgery, vol. 58, no. 4, pp. 1129-1139, 2013.

[31] D. E. Jonas, C. Feltner, H. R. Amick et al., "Screening for asymptomatic carotid artery stenosis: a systematic Review and meta-analysis for the U.S. Preventive services task force," Annals of Internal Medicine, vol. 161, no. 5, p. 336, 2014.

[32] C. S. H. Tan, W. K. Ngo, and K. X. Cheong, "Comparison of choroidal thicknesses using swept source and spectral domain optical coherence tomography in diseased and normal eyes," British Journal of Ophthalmology, vol. 99, no. 3, pp. 354-358, 2014.

[33] S. Ozdogan Erkul, Z. Kapran, and O. M. Uyar, "Quantitative analysis of subfoveal choroidal thickness using enhanced depth imaging optical coherence tomography in normal eyes," International Ophthalmology, vol. 34, no. 1, pp. 35-40, 2013.

[34] M. Moussa, D. Sabry, and W. Soliman, "Macular choroidal thickness in normal Egyptians measured by swept source optical coherence tomography," BMC Ophthalmology, vol. 16, no. 1, p. 138, 2016.

[35] J. W. Shin, Y. U. Shin, H. Y. Cho, and B. R. Lee, "Measurement of choroidal thickness in normal eyes using 3D OCT-1000 spectral domain optical coherence tomography," Korean Journal of Ophthalmology, vol. 26, no. 4, p. 255, 2012.

[36] V. Manjunath, M. Taha, J. G. Fujimoto, and J. S. Duker, "Choroidal thickness in normal eyes measured using cirrus HD optical coherence tomography," American Journal of Ophthalmology, vol. 150, no. 3, pp. 325-329, 2010.

[37] S. E. Chung, S. W. Kang, J. H. Lee, and Y. T. Kim, "Choroidal thickness in polypoidal choroidal vasculopathy and exudative age-related macular degeneration," Ophthalmology, vol. 118, no. 5, pp. 840-845, 2011.

[38] J. Yeoh, W. Rahman, F. Chen et al., "Choroidal imaging in inherited retinal disease using the technique of enhanced depth imaging optical coherence tomography," Graefe's Archive for Clinical and Experimental Ophthalmology, vol. 248, no. 12, pp. 1719-1728, 2010.

[39] I. Maruko, T. Iida, Y. Sugano, M. Saito, and T. Sekiryu, "Subfoveal retinal and choroidal thickness after verteporfin photodynamic therapy for polypoidal choroidal vasculopathy," American Journal of Ophthalmology, vol. 151, no. 4, pp. 594-603, 2011.

[40] E. J. Sigler, J. C. Randolph, J. I. Calzada, and S. Charles, "Smoking and choroidal thickness in patients over 65 with early-atrophic age-related macular degeneration and normals," Eye, vol. 28, no. 7, pp. 838-846, 2014.

[41] S. Wang, Y. Wang, X. Gao, N. Qian, and Y. Zhuo, "Choroidal thickness and high myopia: a cross-sectional study and meta-analysis," BMC Ophthalmology, vol. 15, no. 1, p. 70, 2015.

[42] G. Yiu, S. J. Chiu, P. A. Petrou et al., "Relationship of central choroidal thickness with age-related macular degeneration status," American Journal of Ophthalmology, vol. 159, no. 4, pp. 617-626, 2015.

[43] J. B. Jonas, T. M. Forster, P. Steinmetz, F. C. Schlichtenbrede, and B. C. Harder, "Choroidal thickness in age-related macular degeneration," Retina, vol. 34, no. 6, pp. 1149-1155, 2014.

[44] S. Manabe, C. Shiragami, K. Hirooka, S. Izumibata, A. Tsujikawa, and F. Shiraga, "Change of regional choroid thickness after reduced-fluence photodynamic therapy for chronic central serous chorioretinopathy," American Journal of Ophthalmology, vol. 159, no. 4, pp. 644-651, 2015.

[45] S. Kuroda, Y. Ikuno, Y. Yasuno et al., "Choroidal thickness in central serous chorioretinopathy," Retina, vol. 33, no. 2, pp. 302-308, 2013.

[46] H. Wang, H. Li, X. Zhang, L. Qiu, Z. Wang, and Y. Wang, "Ocular image and haemodynamic features associated with different gradings of ipsilateral internal carotid artery stenosis," Journal of Ophthalmology, vol. 2017, Article ID 1842176, 10 pages, 2017.

[47] K. Riihelainen, M. Paivansalo, I. Suramo, and L. Laatikainen, "The effect of carotid endarterectomy on ocular blood velocity," Ophthalmology, vol. 104, no. 4, pp. 672-675, 1997.

[48] V. P. Costa, S. Kuzniec, L. J. Molnar, G. G. Cerri, P. Puech-Leao, and C. A. Carvalho, "Clinical findings and hemodynamic changes associated with severe occlusive carotid artery disease," Ophthalmology, vol. 104, no. 12, pp. 1994-2002, 1997.

[49] S. Kawaguchi, S. Okuno, T. Sakaki, and N. Nishikawa, "Effect of carotid endarterectomy on chronic ocular ischemic syndrome due to internal carotid artery stenosis," Neurosurgery, vol. 48, no. 2, pp. 328-333, 2001.

[50] V. V. Neroev, T. N. Kiseleva, S. K. Vlasov, N. V. Pak, A. V. Gavrilenko, and A. V. Kuklin, "Visual outcomes after carotid reconstructive surgery for ocular ischemia," Eye, vol. 26, no. 10, pp. 1281-1287, 2012.

[51] F. Lareyre, E. Nguyen, J. Raffort et al., "Changes in ocular subfoveal choroidal thickness after carotid endarterectomy using enhanced depth imaging optical coherence tomography: a pilot study," Angiology, vol. 69, no. 7, pp. 574-581, 2017.

Gilad Rabina [ID], (1) Dana Barequet [ID], (1) Michael Mimouni [ID], (2) Yefim Rabinovitch, (3) Yehuda Wolf, (3) Adiel Barak [ID], (1) Anat Loewenstein, (1) and Shulamit Schwartz [ID] (1)

(1) Division of Ophthalmology, Sourasky Medical Center, Affiliated with Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel

(2) Department of Ophthalmology, Rambam Health Care Campus, Affiliated with the Ruth Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel

(3) Department of Vascular Surgery, Sourasky Medical Center, Affiliated with Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel

Correspondence should be addressed to Michael Mimouni; michael@intername.co.il

Received 28 September 2018; Accepted 25 November 2018; Published 18 December 2018

Academic Editor: Siamak Ansari-Shahrezaei

Caption: Figure 1: Choroid anatomy (histology and OCT). Choroid boundaries measured as the distance between the RPE/choroid interface and choroid/sclera interface. OCT: optical coherence tomography; RPE: retinal pigment epithelium.

Caption: Figure 2: Patient #1: a 61-year-old male, with a past medical history of hypertension, hypercholesterolemia, TIA, and smoking (40 packyears), presented with right ICA stenosis of 80%. His BCVA at presentation was RE 6/6.5 and LE 6/7.5. Mild nuclear sclerosis was present in both eyes with no pathological findings when performing fundoscopy of both eyes. He underwent an uneventful CEA, and on follow-up, there was no right ICA stenosis at all. EDI SD-OCT images of the RE, with choroidal thickness measurements (subfoveal; 500 [micro]m, 1000 [micro]m, and 1500 [micro]m nasal and temporal), obtained one day before right CEA (a) and 6 months after CEA (b). TIA: transient ischemic attack; ICA: internal carotid artery; BCVA: best-corrected visual acuity; RE: right eye; LE: left eye; CEA: carotid artery endarterectomy; EDI: enhanced depth imaging; SD-OCT: spectral domain optical coherence tomography.

Caption: Figure 3: Patient #7: a 75-year-old male, with a past medical history of hypertension, CVA, CAD, hypercholesterolemia, and smoking (40 pack-years), presented with right ICA stenosis of 90%. His BCVA at presentation was RE 6/7.5 and LE 6/7.5. Moderate nuclear sclerosis was present in both eyes with no pathological findings in the funduscopy of both eyes. He underwent an uneventful CEA, and on follow-up, there was no right ICA stenosis at all. EDI SD-OCT images of the RE, with choroidal thickness measurements (subfoveal; 500 [micro]m, 1000 [micro]m, and 1500 [micro]m nasal and temporal), obtained one day before right CEA (a) and 14 months after CEA (b). CVA: cerebrovascular accident; CAD: coronary artery disease; ICA: internal carotid artery; BCVA: best-corrected visual acuity; RE: right eye; LE: left eye; CEA: carotid artery endarterectomy; EDI: enhanced depth imaging; SD-OCT: spectral domain optical coherence tomography.
Table 1: The demographic features and baseline characteristics of
patients.

                                                           p value

Number of patients                        8
Age (mean [+ or -] SD)            70.5 [+ or -] 6.1
                                       (61-77)
Sex, male/female                         7/1                0.008
Hypertension, n (%)                    8 (100)
Hypercholesterolemia, n (%)             6 (75)
Coronary artery disease, n (%)          4 (50)
Tobacco use, n (%)                      5 (62)
TIA, n (%)                              5 (62)
CVA, n (%)                              5 (62)
Diabetes mellitus                       3 (37)
Endarterectomy side,                     5/3                0.35
right/ left

                  Operated side       Nonoperated side

Carotid         89.8 [+ or -] 5.1    33.7 [+ or -] 10.9    >0.0001
stenosis (%)
BCVA (logMAR)   0.35 [+ or -] 0.66   0.61 [+ or -] 0.83     0.51
IOP             15.8 [+ or -] 2.1    15.3 [+ or -] 1.8      0.62

TIA: transient ischemic attack; CVA: cerebrovascular accident;
BCVA: best-corrected visual acuity; IOP: intraocular pressure.

Table 2: Patient characteristics.

                                             Carotid
                                         stenosis before
Serial                     Side of       endarterectomy
no.       Sex     Age   endarterectomy         (%)

1         Male    61        Right              80
2         Male    63         Left              99
3         Male    77        Right              90
4         Male    75        Right              90
5        Female   71         Left              90
6         Male    76        Right              90
7         Male    75        Right              90
8         Male    68         Left              90

            Carotid         Carotid
         stenosis after    stenosis,
Serial   endarterectomy   nonoperated
no.           (%)          side (%)     HTN   TIA   CVA

1              0              50         +     +
2              0              30         +           +
3              0              25         +     +     +
4              0              35         +     +     +
5              0              30         +           +
6              0              20         +     +
7              0              30         +           +
8              0              50         +     +

         Smoker
Serial   (pack-         Hypothy-        Hypercholes-
no.      years)   CAD   roidism    DM    terolemia     COPD

1        + (40)                              +
2        + (50)                              +
3                  +               +
4        + (30)    +       +                 +
5                          +
6        + (40)                    +         +          +
7        + (40)    +                         +          +
8                  +               +         +

HTN: hypertension; TIA: transient ischemic attack;
CVA: cerebrovascular accident; CAD: coronary artery disease;
DM: diabetes mellitus; COPD: chronic obstructive pulmonary disease.

Table 3: CMT and SFChT comparison between the operated and nonoperated
sides.

                          Operated side    Nonoperated side   p value

CMT ([micro]m)           267 [+ or -] 31   271 [+ or -] 19     0.76
SFChT ([micro]m)         277 [+ or -] 67   268 [+ or -] 71     0.81
Choroidal thickness
([micro]m) (relative
to fovea)
500 [micro]m nasal       267 [+ or -] 59   259 [+ or -] 66      0.8
1000 [micro]m nasal      245 [+ or -] 60   248 [+ or -] 56     0.92
1500 [micro]m nasal      292 [+ or -] 57   272 [+ or -] 63     0.52
500 [micro]m temporal    272 [+ or -] 58   258 [+ or -] 67     0.63
1000 [micro]m temporal   257 [+ or -] 71   253 [+ or -] 60     0.89
1500 [micro]m temporal   253 [+ or -] 68   243 [+ or -] 61     0.75

CMT: central macular thickness; SFChT: subfoveal choroidal thickness.

Table 4: CMT and SFChT before and after carotid artery endarterectomy.

                             Before             After
                         endarterectomy     endarterectomy    p value

CMT ([micro]m)           267 [+ or -] 31   268 [+ or -] 29     0.98
SFChT ([micro]m)         277 [+ or -] 67   275 [+ or -] 64     0.96
Choroidal thickness
([micro]m) (relative
to fovea)
500 [micro]m nasal       267 [+ or -] 59   261 [+ or -] 72     0.85
1000 [micro]m nasal      245 [+ or -] 60   244 [+ or -] 76     0.97
1500 [micro]m nasal      292 [+ or -] 57   278 [+ or -] 76     0.74
500 [micro]m temporal    272 [+ or -] 58   271 [+ or -] 53     0.95
1000 [micro]m temporal   257 [+ or -] 71   261 [+ or -] 58     0.91
1500 [micro]m temporal   253 [+ or -] 68   244 [+ or -] 59     0.78

CMT: central macular thickness; SFChT: subfoveal choroidal thickness.
COPYRIGHT 2018 Hindawi Limited
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2018 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Title Annotation:Research Article
Author:Rabina, Gilad; Barequet, Dana; Mimouni, Michael; Rabinovitch, Yefim; Wolf, Yehuda; Barak, Adiel; Loe
Publication:Journal of Ophthalmology
Geographic Code:7ISRA
Date:Jan 1, 2018
Words:5204
Previous Article:Efficacy and Safety of an Aflibercept Treat-and-Extend Regimen in Treatment-Naive Patients with Macular Oedema Secondary to Central Retinal Vein...
Next Article:Clinical Outcomes of Sequential Intrastromal Corneal Ring Segments and an Extended Range of Vision Intraocular Lens Implantation in Patients with...
Topics:

Terms of use | Privacy policy | Copyright © 2020 Farlex, Inc. | Feedback | For webmasters